Sie sind auf Seite 1von 2

New Study Confirms TwitchView® Quantitative Monitor for Neuromuscular

Blockade is Comparable to Gold Standard Mechanomyography

Seattle, WA, October 18, 2019 --( Blink Device Company announced today that a study
comparing the TwitchView® quantitative train-of-four (TOF) electromyography-based monitor to
accelerometry and mechanomyography has been published in the journal Anaesthesia ( The results demonstrate that the TwitchView
monitor closely resembles mechanomyography, often considered to be the laboratory gold standard, while
accelerometry frequently produces train-of-four ratio values > 1.0, complicating the interpretation of
acceleromyography results in the clinical setting.

Justin Hulvershorn, MD, PhD, Blink's CEO said, “Neuromuscular blocking drugs are used in almost 50%
of surgeries. The literature shows that, in the absence of quantitative monitoring, nearly 4 out of every 10
patients will wake up from these surgeries with residual paralysis, which delays recovery and can lead to
significant complications. To help prevent these complications, quantitative neuromuscular monitoring is
becoming the standard of care when neuromuscular blocking agents are administered. In the past,
monitors have been difficult to use and have not performed reliably. We developed the TwitchView to
make quantitative TOF monitoring as accessible as monitoring other vital signs, like blood pressure or
oxygen saturation.”

Andrew Bowdle, MD, PhD, the study's lead author noted, “Our research team at the University of
Washington has spent the last two years studying a wide range of quantitative TOF monitors, as well as
using these monitors in routine patient care. TwitchView is very accurate and reliable, as shown in our
study. Other devices that we tested had significant shortcomings. The TwitchView is very easy-to-use
and, unlike acceleromyography, functions reliably even when the patient's arm is tucked for surgery. We
are in the process of implementing TwitchView in the UWMedicine hospitals as our standard for clinical

About Blink Device Company

Blink Device Company is headquartered in Seattle, Washington and their products are proudly made in
the USA. To learn more, visit

If you would like more information, please email Elise Hyman at

Page 1/2 Press Release Distribution Terms of Use
Contact Information:
Blink Device Company
Elise Hyman
(312) 852-0064
Contact via Email

Online Version of Press Release:

You can read the online version of this press release at:

News Image:

Page 2/2 Press Release Distribution Terms of Use